valomaciclovir

Known as: ((3R)-3-((2-amino-6-oxo-3H-purin-9-yl)methyl)-4-hydroxy-butyl) (2S)-2-amino-3-methyl-butanoate, L-Valine, 4-ester with 9-((R)-4-hydroxy-2-(hydroxymethyl)butyl)guanine 
A prodrug form of the acyclic guanosine derivative omaciclovir with activity against varicella zoster virus (VZV) and other members of the… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

2011-2017
01220112017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
OBJECTIVE The review covers basic principles of the prodrug strategy applied to antiviral nucleoside drugs or drug candidates… (More)
Is this relevant?
Review
2016
Review
2016
BACKGROUND Infectious mononucleosis (IM) is a clinical syndrome, usually caused by the Epstein Barr virus (EPV), characterised by… (More)
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
Review
2015
Review
2015
PURPOSE OF REVIEW The mainstay of antiviral therapy for the alpha-herpesviruses [herpes simplex virus (HSV)-1, HSV-2, and… (More)
  • table 1
Is this relevant?
Review
2013
Review
2013
Varicella-zoster virus (VZV) causes two distinct diseases, varicella (chickenpox) and shingles (herpes zoster). Chickenpox occurs… (More)
Is this relevant?
2012
2012
Herpes zoster is a common infectious disease that can result in significant acute and chronic morbidity. The safety and efficacy… (More)
Is this relevant?
Review
2011
Review
2011
Resurgent interest in antiviral drugs for the treatment of herpesvirus has led to the development of new compounds that are… (More)
Is this relevant?
Review
2011
Review
2011
INTRODUCTION Varicella-zoster virus (VZV) is the etiological agent of two distinct diseases, varicella (chickenpox) and shingles… (More)
Is this relevant?